Literature DB >> 3345849

The ribosomes of Aspergillus giganteus are sensitive to the cytotoxic action of alpha-sarcin.

S P Miller1, J W Bodley.   

Abstract

Ribosomes in lysates prepared from the mycelia of Aspergillus giganteus MDH 18894, which are actively secreting alpha-sarcin, do not contain the alpha-sarcin lesion. However, the addition of exogenous alpha-sarcin to these same lysates results in cleavage of the 26 S rRNA of the 60 S ribosomal subunit, characteristic of the cytotoxic action of alpha-sarcin. We conclude that A. giganteus ribosomes are not inherently resistant to the action of alpha-sarcin but are protected in vivo by producing alpha-sarcin in an inactive form and/or by the efficient cotranslational secretion of the toxin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3345849     DOI: 10.1016/0014-5793(88)81162-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Involvement of the amino-terminal beta-hairpin of the Aspergillus ribotoxins on the interaction with membranes and nonspecific ribonuclease activity.

Authors:  L García-Ortega; J Lacadena; J M Mancheño; M Oñaderra; R Kao; J Davies; N Olmo; J G Gavilanes
Journal:  Protein Sci       Date:  2001-08       Impact factor: 6.725

2.  Construction, expression and characterization of chimaeric toxins containing the ribonucleolytic toxin restrictocin: intracellular mechanism of action.

Authors:  D Rathore; J K Batra
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

3.  Transformation of Aspergillus giganteus to hygromycin B resistance.

Authors:  S Wnendt; M Jacobs; U Stahl
Journal:  Curr Genet       Date:  1990-01       Impact factor: 3.886

Review 4.  Fungal Ribotoxins: A Review of Potential Biotechnological Applications.

Authors:  Miriam Olombrada; Rodrigo Lázaro-Gorines; Juan C López-Rodríguez; Álvaro Martínez-Del-Pozo; Mercedes Oñaderra; Moisés Maestro-López; Javier Lacadena; José G Gavilanes; Lucía García-Ortega
Journal:  Toxins (Basel)       Date:  2017-02-21       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.